Two Novel NF1 Pathogenic Variants Causing the Creation of a New Splice Site in Patients With Neurofibromatosis Type I
Open Access
- 22 August 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 10, 762
Abstract
Neurofibromatosis type I (NF1) is one of the most common autosomal dominant disorders, since the estimated incidence is one in 3,500 births. In this study, we present bioinformatical and functional characterization of two novel splicing NF1 variants, detected in NF1 patients. Patient 1, carrying NF1:c.122A>T, which introduces a new exonic 5’ donor splice site, was diagnosed with hormone-positive, Her-2-negative breast cancer at the age of 47. She had an atypical presentation of NF1, with few café-au-lait spots and no Lisch nodules. Patient developed a hemothorax due to subclavian artery rupture, which has previously been described as an extremely rare complication of NF1. Patient 2, carrying NF1:c.7395-17T>G that creates a new intronic 3’ acceptor splice site, had quite a typical clinical presentation of NF1: formations on her tongue in the region of her left metacarpal bones and on her left foot, plexiform neurofibroma in her pelvis, several café-au-lait spots, and axillary freckling. She was also diagnosed with cognitive impairment. In the report, we are presenting two novel variants which were successfully classified based on NGS and mRNA analysis. Based on results of mRNA analysis, both variants were classified as likely pathogenic according to ACMG guidelines applying evidence categories PS3, PM2, PP3, and PP1 supporting. By characterizing those two novel NF1 splicing variants, we have confirmed the neurofibromatosis type I phenotype in the two probands.Keywords
This publication has 23 references indexed in Scilit:
- Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1Journal of Clinical Oncology, 2016
- Identification and characterization of NF1 splicing mutations in Korean patients with neurofibromatosis type 1Journal of Human Genetics, 2016
- Advances in Molecular Diagnosis of Neurofibromatosis Type 1Seminars in Pediatric Neurology, 2015
- RNA mis-splicing in diseaseNature Reviews Genetics, 2015
- A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressorNature Reviews Cancer, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Nature and mRNA effect of 282 differentNF1point mutations: focus on splicing alterationsHuman Mutation, 2008
- Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5′ splice-site disruptionHuman Mutation, 2007
- Disruption of exonic splicing enhancer elements is the principal cause of exon skipping associated with seven nonsense or missense alleles of NF1Human Mutation, 2004
- Listening to silence and understanding nonsense: exonic mutations that affect splicingNature Reviews Genetics, 2002